Terms: = Breast cancer AND CTNNB1, P35222, 1499, ENSG00000168036, CTNNB AND Clinical Outcome
1 results:
1. β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with ctnnb1 mutation.
Geyer FC; Lacroix-Triki M; Savage K; Arnedos M; Lambros MB; MacKay A; Natrajan R; Reis-Filho JS
Mod Pathol; 2011 Feb; 24(2):209-31. PubMed ID: 21076461
[TBL] [Abstract] [Full Text] [Related]
